Human genetics: Methylation moves into medicine

Current Biology

Volumn 10, Issue 2, 2000, Pages

  Hendrich, Brian ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MAMMALIA;

DNA METHYLTRANSFERASE;

DNA METHYLATION; GENETICS; HUMAN; MEDICAL GENETICS; METABOLISM; MUTATION; RETT SYNDROME; REVIEW; SYNDROME;

DNA METHYLATION; DNA MODIFICATION METHYLASES; GENETICS, MEDICAL; HUMANS; MUTATION; RETT SYNDROME; SYNDROME;

EID: 0033952930     PISSN: 09609822     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0960-9822(00)00286-4     Document Type: Article

References (17)

1. Li E, Bestor TH, Jaenisch R: Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 1992, 69:915-926.
2. Maraschio P, Zuffardi O, Dalla Fior T, Tiepolo L: Immunodeficiency, centromeric heterochromatin instability of chromosomes 1, 9, and 16, and facial anomalies: the ICF syndrome. J Med Genet 1988, 25:173-180.
3. Jeanpierre M, Turleau C, Aurias A, Prieur M, Ledeist F, Fischer A, Viegas-Pequignot E: An embryonic-like methylation pattern of classical satellite DNA is observed in ICF syndrome. Hum Mol Genet 1993, 2:731-735.
4. Wijmenga C, van den Heuvel LP, Strengman E, Luyten JA, van der Burgt U, de Groot R, Smeets DF, Draaisma JM, van Dongen JJ, De Abreu RA, et al.: Localization of the ICF syndrome to chromosome 20 by homozygosity mapping. Am J Hum Genet 1998, 63:803-809.
5. Robertson KD, Uzvolgyi E, Liang G, Talmadge C, Sumegi J, Gonzales FA, Jones PA: The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors. Nucleic Acids Res 1999, 27:2291-2298.
6. Hansen RS, Wijmenga C, Luo P, Stanek AM, Canfield TK, Weemaes CMR, Gartler SM: The DNMT3B DNA methyltransferase gene is mutated in the ICF immunodeficiency syndrome. Proc Natl Acad Sci USA 1999, 96:14412-14417.
7. Okano M, Bell DW, Haber DA, Li E: DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 1999, 99:247-257.
8. Xu G-L, Bestor TH, Bourc'his D, Hsieh C-L, Tommerup N, Bugge M, Hulten M, Qu X, Russo JJ, Viegas-Péquignot E: Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene. Nature 1999, 402:187-191.
9. Amir RE, Van Den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY: Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 1999, 23:185-188.
10. Wan M, Lee SSJ, Zhang X, Houwink-Manville I, Song H-R, Amir RE, Budden S, Naidu S, Pereira JLP, Lo IFM, et al.: Rett Syndrome and beyond: recurrent spontaneous and familial MECP2 mutations at CpG hotspots. Am J Hum Gene 1999, 65:1520-1529.
11. Hagberg B, Aicardi J, Dias K, Ramos O: A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett's syndrome: report of 35 cases. Ann Neurol 1983, 14:471-479.
12. Kerr AM, Stephenson JB: Rett's syndrome in the west of Scotland. Br Med J (Clin Res Ed) 1985, 291:579-582.
13. Zoghbi H: Genetic aspects of Rett syndrome. J Child Neurol 1988, 3 (suppl):S76-S78.
14. Engerstrom IW, Kerr A: Workshop on autonomic function in Rett syndrome. Brain Dev 1988, 20:323-326.
15. Nan X, Campoy F, Bird A: MeCP2 is a transcriptional represser with abundant binding sites in genomic chromatin. Cell 1997, 88:471-481.
16. Tate P, Skarnes W, Bird A: The methyl-CpG binding protein MeCP2 is essential for embryonic development in the mouse. Nat Genet 1996, 12:205-208.
17. Wakefield RI, Smith BO, Nan X, Free A, Soteriou A, Uhrin D, Bird AP, Barlow PN: The solution structure of the domain from MeCP2 that binds to methylated DNA. J Mol Biol 1999, 291:1055-1065.